Integra LifeSciences Announces 1,000th Implant of NeuraGen Nerve Guide for Peripheral Nerve Repair
April 29, 2003 16:03 ET
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, N.J., April 29, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported that more than 1,000 NeuraGen(TM) Nerve Guides have been implanted in patients...
Integra LifeSciences Reports Record Pre-Tax Earnings and Revenues for the First Quarter 2003
April 25, 2003 07:00 ET
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, N.J., April 25, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported net income of $5.4 million, or $0.18 per share, for the first quarter of 2003,...
Integra LifeSciences Holdings Corporation to Sell Additional $20 Million of Contingent Convertible Subordinated Notes
April 11, 2003 08:00 ET
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, N.J., April 11, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced that the initial purchasers of its 2.5% Contingent Convertible Subordinated Notes due...
Integra LifeSciences Schedules Conference Call for Friday, April 25 to Discuss First Quarter 2003 Financial Results and Update Forward-Looking Financial Guidance
April 09, 2003 08:00 ET
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, N.J., April 9, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced that it has scheduled a conference call for 9:00 AM EST on Friday, April 25 to discuss...
Integra LifeSciences Confirms Earnings Guidance
March 26, 2003 09:41 ET
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, N.J., March 26, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that the Company's guidance for earnings per share of $0.16 for the first...
Integra LifeSciences Holdings Corporation to Sell $100 Million of Contingent Convertible Subordinated Notes
March 26, 2003 09:39 ET
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, N.J., March 26, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced that it has agreed to sell $100 million principal amount of its 2.5% contingent...
Integra LifeSciences Holdings Corporation Announces Proposed $100 Million Contingent Convertible Subordinated Notes Offering
March 26, 2003 06:01 ET
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, N.J., March 26, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it intends to offer $100 million of contingent convertible subordinated...
Integra LifeSciences Announces Acquisition of JARIT Surgical Instruments; Raises Revenue and Earnings Guidance
March 18, 2003 09:20 ET
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, N.J., March 18, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has acquired JARIT(R) Surgical Instruments for approximately $44.5...
Integra LifeSciences Reports Record Earnings and Revenues for the Fourth Quarter and Full Year 2002
February 27, 2003 07:30 ET
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, N.J., Feb. 27, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported record revenues and net income for the fourth quarter and full year 2002. Total...
Integra LifeSciences Schedules Conference Call for Thursday, February 27 to Discuss Fourth Quarter and Full Year 2002 Financial Results and Update Forward-Looking Financial Guidance
February 19, 2003 12:45 ET
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, N.J., Feb. 19, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced that it has scheduled a conference call for 9:00 AM EST on Thursday, February 27 to...